Kolexia
Steg Philippe
Cardiologie
Hôpital Bichat-Claude-Bernard
Paris, France
1.2 K Activités
2.8 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infarctus du myocarde Infarctus Syndrome coronarien aigu Maladie des artères coronaires Hémorragie Accident vasculaire cérébral Thrombose Infarctus du myocarde avec sus-décalage du segment ST Ischémie myocardique

Industries

Sanofi
52 collaboration(s)
Dernière en 2023
Novartis
44 collaboration(s)
Dernière en 2023
AstraZeneca
28 collaboration(s)
Dernière en 2023
Amarin
17 collaboration(s)
Dernière en 2023

Dernières activités

Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.
American heart journal   06 mars 2024
Prevalence of self-reported severe periodontitis: Data from the population-based CONSTANCES cohort.
Journal of clinical periodontology   02 mars 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
Journal of the American College of Cardiology   01 mars 2024
Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis.
The Canadian journal of cardiology   24 février 2024
REVERSE-IT: A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Essai Clinique (SFJ Pharmaceuticals, Inc.)   14 février 2024
AMISLEEP: SDB Prevalence and Cardiovascular Outcomes of MI Survivors
Essai Clinique (Assistance publique – Hôpitaux de Paris)   13 février 2024
Impact of the 2021 ESC Prevention Guideline's stepwise approach for cardiovascular risk factor treatment in patients with established ASCVD.
European journal of preventive cardiology   07 février 2024
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial.
Circulation   22 janvier 2024
Observational studies play little role in guiding evidence-based medicine: pros and cons.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology   16 janvier 2024
Sotagliflozin Reduces The Risk Of Cardiovascular Events In Patients With Left Ventricular Hypertrophy Without Hypertension: A Post Hoc Analysis From SCORED
Journal of cardiac failure   01 janvier 2024